HALB Company Profile and Key Details

Q: Who are the executives of HALB?

Ms. Heidi H. CarlDirector & Accounting DirectorDr. Mitchell S. Felder M.D.Chief Technology Officer & Member of the Scientific Advisory BoardDr. Patricio F. Reyes FAAN, M.D.Chief Mechanical Officer & Member of the Scientific Advisory BoardMr. William A. HartmanPres, Chief Executive Officer & ChairmanMr. John S. Borza AVS, MBA, PEChief Operating Officer & Director

PNK : HALB

Halberd

$0.01

-0.0013-13.98%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Halberd Corporation (HALB) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.

Stock Snapshot

0.0008

Prev. Close

412.7K

Market Cap

0.0008

Day Low

N/A

P/E Ratio

N/A

EPS (TTM)

Cash Flow per Share

Open

515.88M

Number of Shares

0.00084

Day High

50.42%

Free Float in %

Book Value

400

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	0.00	0.00	0.00	0.00	310.9K
Sep 09, 2026	0.00	0.00	0.00	0.00	315
Sep 08, 2026	0.00	0.00	0.00	0.00	500
Sep 03, 2026	0.00	0.00	0.00	0.00	1K
Sep 02, 2026	0.00	0.00	0.00	0.00	330K
Sep 01, 2026	0.00	0.00	0.00	0.00	5K
Aug 31, 2026	0.00	0.00	0.00	0.00	179.72K
Aug 27, 2026	0.00	0.00	0.00	0.00	27.5K
Aug 26, 2026	0.00	0.00	0.00	0.00	110.71K
Aug 25, 2026	0.00	0.00	0.00	0.00	15K
Aug 24, 2026	0.00	0.00	0.00	0.00	810K
Aug 21, 2026	0.00	0.00	0.00	0.00	49.75K
Aug 20, 2026	0.00	0.00	0.00	0.00	90K
Aug 19, 2026	0.00	0.00	0.00	0.00	540K
Aug 18, 2026	0.00	0.00	0.00	0.00	400
Aug 17, 2026	0.00	0.00	0.00	0.00	324.1K
Aug 14, 2026	0.00	0.00	0.00	0.00	932.44K
Aug 13, 2026	0.00	0.00	0.00	0.00	0
Aug 12, 2026	0.00	0.00	0.00	0.00	7K
Aug 11, 2026	0.00	0.00	0.00	0.00	316.91K

Contact Details

Jackson Center, PA 16133

United States

https://halberdcorporation.com 814 786 8849

About Company

Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Company Overview

The stock is currently mid-range between its 52-week high and low $0.00 and $0.00. With a market capitalization of about $412.70 thousand, Halberd Corporation is classified as a micro-cap and shows lower-than-market volatility (beta ~0.13). Key stats such as the average daily volume over the past year has been around 526.95 thousand shares, volume is running light vs its 52-week average. Headquartered in Jackson Center, PA, Halberd Corporation operates in the Healthcare sector and the Biotechnology industry. Led by CEO William A. Hartman, the company employs approximately 3 people and listed since September 25, 2012. Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions.

Technical Performance

Average 10-day trading volume of 118.21 thousand shares is below the 3-month average of 569.12 thousand, indicating normal recent market interest.

Valuation Metrics

Halberd Corporation trades at a P/E ratio of -13.2, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -0.67 indicating negative book value, which may reflect financial stress. The P/FCF stands at 0.0, also above market averages.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Financial & Profitability Overview

Over the trailing twelve months, Halberd has not generated any revenue. Returns are negative, with ROA at -447.41% and ROE at 2.20%.
On valuation metrics, Halberd trades at a P/E of -13.20, P/S of 0.00 and P/B of -0.67. Liquidity is tight, with a current ratio of 0.00 and quick ratio of 0.00. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -353275.46 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is -0.17, supported by a cash flow-to-debt ratio of 0.00.

Quarterly Financial Highlights

For the quarter ended Jul 31, 2025, Halberd posted revenue of $0.00, down slightly from $999.00 in the prior quarter. Gross profit was - $549.00 (margin 0.00%). Operating income was - $18.67K (margin 0.0%). Net income was- $20.07K (EPS $0.00).
The company ended the quarter with $0.00 in cash and short-term investments, a total debt of $150.00K, and net debt of $150.00K. Total assets were $4.49K, with equity of - $913.11K. Financials further reflected weakness, with operating cash flow of - $240.74K, free cash flow of - $240.74K, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that Halberd Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Halberd Corporation trading at a premium to the broader market with a P/E of -13.2.

Frequently Asked Questions

What is the current Halberd Corporation (HALB) stock price?

Halberd Corporation (OTC: HALB) stock price is $0.00 in the last trading session. During the trading session, HALB stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in HALB stock occurred in the recent session was 0% while the dollar amount for the price change in HALB stock was $0.00.

HALB's industry and sector of operation?

The OTC listed HALB is part of Biotechnology industry that operates in the broader Healthcare sector. Halberd Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HALB?

Ms. Heidi H. Carl
Director & Accounting Director
Dr. Mitchell S. Felder M.D.
Chief Technology Officer & Member of the Scientific Advisory Board
Dr. Patricio F. Reyes FAAN, M.D.
Chief Mechanical Officer & Member of the Scientific Advisory Board
Mr. William A. Hartman
Pres, Chief Executive Officer & Chairman
Mr. John S. Borza AVS, MBA, PE
Chief Operating Officer & Director

How HALB did perform over past 52-week?

HALB's closing price is 166.67% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.00 is -34.43%.

How many employees does HALB have?

Number of HALB employees currently stands at 3.

Link for HALB official website?

Official Website of HALB is: https://halberdcorporation.com

How do I contact HALB?

HALB could be contacted at phone 814 786 8849 and can also be accessed through its website. HALB operates from PO Box 25, Jackson Center, PA 16133, United States.

How many shares of HALB are traded daily?

HALB stock volume for the day was 400 shares. The average number of HALB shares traded daily for last 3 months was 526.95K.

What is the market cap of HALB currently?

The market value of HALB currently stands at $412.70K with its latest stock price at $0.00 and 515.88M of its shares outstanding.

Employees	3
Beta	0.13
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	July
Sector	Healthcare
Industry	Biotechnology

HALB Company Profile and Key Details

Halberd

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Dividend & Fair Value

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook

Valuation Metrics